Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Exploring the molecular diversity and biomedicinal potential of marine invertebrates and South African actinomycetes for tuberculosis drug discovery
Tuberculosis (TB) which is caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death from a single infectious disease and remains a global health threat. Although there is medicine for treating TB, it still kills millions each year. This is due to a lengthy and demanding TB treatment...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Chemistry
2022
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Exploring the molecular diversity and biomedicinal potential of marine invertebrates and South African actinomycetes for tuberculosis drug discovery
- Investigating the chemical diversity and biomedicinal potential of South African actinomycetes for tuberculosis drug discovery
- In Silico Molecular Docking of Marine Drugs Against Cancer Proteins
- Nanobodies as next‐generation targeting platforms: From discovery technologies to translational biomedicine
- Isolation and characterisation of antibiotic-producing marine actinomycetes
- Utilization of the Baylis-Hillman and related reactions in antiparasitic drug discovery
- Repurposing chlorpromazine and its metabolites for antituberculosis drug discovery